Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers and authorities are adapting to the strain on resources that genomic medicine can contribute to. Professor Szucs also evaluates the sustainability of personalized medicine and China’s rapid progress in the field.
The evolution of genomic medicine needs to be accompanied by the willingness of the hospital system – and to some extent, the payer system as well – to embrace these new technologies
